Remove 2023 Remove Invention Remove Litigation Remove Patent Prosecution
article thumbnail

[Sponsored] Registration Deadline Extended for the “Comprehensive Course on Patents” Organized by The IP Press In Collaboration with S. Majumdar & Co. (October 5-November 23)

SpicyIP

(October 5-November 23) Following a favorable outcome of preparing students and professionals for the patent agent exam and providing them with a comprehensive guide on Patents in 2022 and 2023. The IP Press presents the third cohort of the Comprehensive Course on Patents. Majumdar & Co.,

article thumbnail

Is the Federal Circuit facing a Chronic Problem of Inequitable Conduct?

Patently-O

2023) This case is still pending before the Federal Circuit, but I found it interesting enough for a preview. United Cannabis holds a broad marijuana patent – US9730911 – with claims directed to a liquid cannabinoid having 95% of either THC or CBD. United Cannabis Corporation v. Pure Hemp Collective Inc. 22-01363 (Fed.

Copying 94
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Who’s Looking at the Quality of Decisions Granting Patents? Some Concerns from the Man Truck v. Asst. Controller Case

SpicyIP

Where the impugned order from the patent office (dated March 18, 2021) ran for 12 pages, the grant order (dated March 05. 2023) resolves the controversy merely in 5 lines. The impugned order also failed to consider the patent granted to the subject invention in different jurisdiction.

Patent 45
article thumbnail

SpicyIP Tidbits – Natco’s Request to Vacate Ceritinib Interim Injunction Rejected, Madras High Court Revokes Omega Ecotech’s Patent, and Delhi High Court Upholds IPO’s Patent Rejection

SpicyIP

DHC Rejects Natco’s Request to Vacate Ceritinib Interim Injunction In a detailed order passed on January 9, 2023, the Delhi High Court had granted an interim injunction to Novartis against Natco, restricting the latter from manufacturing and selling its generic version of Ceritinib, a drug used in treating lung cancer.

Patent 45
article thumbnail

Vanda Seeks Supreme Court Review on Lower Standard for Obviousness

Patently-O

Vanda Pharmaceuticals recently filed a petition for writ of certiorari , asking the Supreme Court to review a May 2023 decision by the Federal Circuit that invalidated claims from four Vanda patents covering methods of treating Non-24-Hour Sleep-Wake Disorder (“Non-24”) using the drug tasimelteon (Hetlioz).

Art 81
article thumbnail

Delhi High Court grants interim injunction to Novartis against Natco’s use of Revolade patent 

SpicyIP

The debate at the crux of the dispute is, or rather was, the dichotomy between deference to the validity of a granted patent vis-a-vis the challenge to its validity and consequently disregarding the exclusivity granted to it, in litigation. The Drug and the patent. The Litigation. Background . See here and here ).

Patent 96
article thumbnail

Spicy IP Weekly Review (December 11 to December 17)

SpicyIP

He is interested in IP law, and commercial and criminal litigation. From conflicting positions on AI as a co-author of a work to the contours of information required u/s 39 about the patent applications filed abroad, we had some engaging posts on this blog this week. Sidhi is a final year B.A.

IP 59